Submission Details
| 510(k) Number | K925826 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 1992 |
| Decision Date | January 26, 1993 |
| Days to Decision | 71 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K925826 is an FDA 510(k) clearance for the ENCORE THYROGLOBULIN IGE, IGA AND IGM EIA. This device is classified as a System, Test, Thyroid Autoantibody (Class II — Special Controls, product code JZO).
Submitted by Clark Laboratories, Inc. (Blairstown, US). The FDA issued a Cleared decision on January 26, 1993, 71 days after receiving the submission on November 16, 1992.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5870.
| 510(k) Number | K925826 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 1992 |
| Decision Date | January 26, 1993 |
| Days to Decision | 71 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | JZO — System, Test, Thyroid Autoantibody |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5870 |